Home › Raleigh's BioDelivery ups patient enrollment in pain ointment trial
 

Keywords :   


Raleigh's BioDelivery ups patient enrollment in pain ointment trial

2014-12-10 03:55:04| Biotech - Topix.net

After expanding a drug trial to test a pain treatment gel, Raleigh drug developer BioDelivery Sciences International reached a milestone in testing that gel it plans to market as a pain medication. Earlier this year, preliminary test results on the gel, called Clonodine Topical Gel, weren't giving BioDelivery what it hoped for, so it upped the enrollment projections from 140 patients to 220 patients.

Tags: trial ups pain patient

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.09Eastern North Pacific Tropical Weather Outlook
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 12
28.09Tropical Storm Joyce Graphics
28.09Hurricane Isaac Wind Speed Probabilities Number 12
28.09Hurricane Isaac Forecast Advisory Number 12
28.09Hurricane Isaac Public Advisory Number 12
28.09Summary for Hurricane Isaac (AT5/AL102024)
More »